Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
29.92
+0.05 (0.17%)
Feb 21, 2025, 4:00 PM EST - Market closed
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.50 billion as of February 21, 2025. Its market cap has decreased by -59.73% in one year.
Market Cap
1.50B
Enterprise Value
1.08B
1-Year Change
-59.73%
Ranking
Category
Stock Price
$29.92
Market Cap Chart
Since the IPO on February 5, 2021, Immunocore Holdings's market cap has increased from $1.08B to $1.50B, an increase of 38.01%. That is a compound annual growth rate of 8.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.50B | 1.42% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | 38.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |